Mr. Yi Zhang, our founder and chairman, has over 35 years of experience in China’s biopharmaceutical industry and has led various successful national research projects, including the National 863 Scientific Project “SARS immunoglobulin” and our National Key New Medical Innovation projects on the PIKA rabies vaccine. Mr. Zhang has the first-hand experience in epidemiology, infectious disease control and vaccination campaigns through local CDC offices in China. Mr. Zhang is the lead author of a number of research publications, co-holder of multiple patents, and inventor of several technologies. Mr. Zhang graduated from Kaifeng Health Science School in October 1981 with a major in clinical medicine. Mr. Zhang is also the director of the Henan Red Cross Society.